Ravulizumab in adults and children with atypical hemolytic uremic syndrome: a plain language summary of three studies
This summary gives an overview of three published articles that report the results of research studies of ravulizumab, an approved treatment for people with atypical hemolytic uremic syndrome (often shortened to aHUS). This is a rare and serious condition where blood clots form in small blood vessel...
Saved in:
Main Authors: | Michal Nowicki (Author), Nikoleta Printza (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies
by: Florencia Aguirre, et al.
Published: (2024) -
Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome
by: Teri J Mauch, et al.
Published: (2023) -
Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome
by: Antonio F. Saad, et al.
Published: (2016) -
Atypical hemolytic uremic syndrome and eculizumab therapy in children
by: Seong Heon Kim, et al.
Published: (2018) -
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
by: Sara Madureira Gomes, et al.
Published: (2021)